Compared with the DC group, the phosphorylation levels of IRS1 (58.62%), PI3K (85.05%), and Akt (108.76%) were significantly increased in T2DM mice receiving a high dose of the CJE treatment (Figure 7A–C). The gene discussed is AKT1; the disease is type 2 diabetes mellitus.